How does Aimovig work to prevent migraine?
Medically reviewed by Drugs.com Last updated on Jun 19, 2018.
Official Answerby Drugs.com
Aimovig (erenumab-aooe) works to help prevent chronic migraine headaches by blocking the activity of calcitonin gene-related peptide (CGRP), a molecule that is involved in migraine attacks and rises during an attack.
The calcitonin gene-related peptide (CGRP) receptor antagonists are a new class of drugs for migraine. Aimovig, from Amgen, is also the first fully human monoclonal antibody for migraine prevention. This treatment for adults is given once-a-month by subcutaneous (under the skin) self-injections with an auto-injector type pen or a single-dose prefilled syringe.
Related Drug Information
- Aimovig Information for Consumers
- Aimovig Information for Healthcare Professionals (includes dosage details)
- Side Effects of Aimovig (detailed)